|Slideshows|February 3, 2017

6 Unique Functions of Psychiatrists in Primary Care

In some segments of the evolving health care system, primary health care teams with psychiatry at their core are becoming a reality. Here are 6 ways psychiatrists add value to primary care health teams.

View the slides in PDF format. Also see: A Landmark Report on Addiction by Our Nation’s Doctor.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Building Community in Psychiatric Practice: Reflections From a Psych NP and Educator

ByFrank A. Clark, MD,Lindsay Hill, DNP, PMHNP

May 1st 2026

MD-MOSAIC: A Proposed Psychiatrist’s Guide for Assessment of Altered Mental Status in Mechanically Ventilated Patients With Critical Illness

ByElisabeth Dietrich, MD,Ruhan Farsin, MD,Melissa P. Bui, MD

April 28th 2026

Should Accrediting Bodies Require AI for Suicide Risk Stratification in Emergency Settings? A Debate

BySarah Cheema, MD,Andrew Canto, MD,Nicolas Badre, MD

April 6th 2026

Why Are Assisted Suicide and Euthanasia Not Accepted in Eastern Cultures?

ByRonald W. Pies, MD,Cynthia M.A. Geppert, MD, PhD, MA, MPH, MSBE, DPS, MSJ,Mark S. Komrad, MD, DFAPA

April 3rd 2026

Culture as Wind: Adapting Recovery and Shared Decision-Making Across Cultures

ByYasuhiro Kotera, PhD

March 25th 2026

Latest CME

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

6 Unique Functions of Psychiatrists in Primary Care

Related Content

Building Community in Psychiatric Practice: Reflections From a Psych NP and Educator

MD-MOSAIC: A Proposed Psychiatrist’s Guide for Assessment of Altered Mental Status in Mechanically Ventilated Patients With Critical Illness

Should Accrediting Bodies Require AI for Suicide Risk Stratification in Emergency Settings? A Debate

Why Are Assisted Suicide and Euthanasia Not Accepted in Eastern Cultures?

Culture as Wind: Adapting Recovery and Shared Decision-Making Across Cultures

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Vol 43, Issue 7 - Interactive

Psychedelics, Orexin Blockers, and More: Inside the Diverse New Pipeline for Depression

Long-Acting Injectables in Schizophrenia: Closing the Gap Between Evidence and Practice

Beyond Deprescribing: A Formula for Excellent Clinical Care

COMP360 Psilocybin in Treatment-Resistant Depression: Insights From Gus Alva, MD, DFAPA